Exact Mass: 245.1739

Exact Mass Matches: 245.1739

Found 65 metabolites which its exact mass value is equals to given mass value 245.1739, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Dezocine

5,11-Methanobenzocyclodecen-3-ol, 13-amino-5,6,7,8,9,10,11,12-octahydro-5-methyl-, (5alpha,11alpha,13S*)

C16H23NO (245.178)


Dezocine is a partial opiate drug and is used for pain management. Dezocine is a very effective alternative to fentanyl when administered during outpatient laparoscopy, although is associated with an increased incidence of postoperative nausea. D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002491 - Central Nervous System Agents > D000700 - Analgesics N - Nervous system > N02 - Analgesics > N02A - Opioids

   

Fawcettidine

Fawcettidine

C16H23NO (245.178)


   

Valyllysine

(2S)-6-amino-2-[(2S)-2-amino-3-methylbutanamido]hexanoic acid

C11H23N3O3 (245.1739)


Valyllysine is a dipeptide composed of valine and lysine. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Lysylvaline

(2S)-2-[(2S)-2,6-diaminohexanamido]-3-methylbutanoic acid

C11H23N3O3 (245.1739)


Lysylvaline is a dipeptide composed of lysine and valine. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Pinacidil

N-cyano-N-(1,4-dihydropyridin-4-ylidene)-N-(3,3-dimethylbutan-2-yl)guanidine

C13H19N5 (245.164)


C - Cardiovascular system > C02 - Antihypertensives > C02D - Arteriolar smooth muscle, agents acting on > C02DG - Guanidine derivatives C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D049990 - Membrane Transport Modulators

   

Centroton

1-(4-methylphenyl)-2-(pyrrolidin-1-yl)pentan-1-one

C16H23NO (245.178)


   

Dehydrolycopecurine

5-Ketone-lycopecurine

C16H23NO (245.178)


   

Anhydrolycodoline

Anhydrolycodoline

C16H23NO (245.178)


   

tolperisone

tolperisone

C16H23NO (245.178)


M - Musculo-skeletal system > M02 - Topical products for joint and muscular pain > M02A - Topical products for joint and muscular pain M - Musculo-skeletal system > M03 - Muscle relaxants > M03B - Muscle relaxants, centrally acting agents D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents C78281 - Agent Affecting Musculoskeletal System > C29696 - Muscle Relaxant D002491 - Central Nervous System Agents

   

PYROVALERONE

PYROVALERONE

C16H23NO (245.178)


D002491 - Central Nervous System Agents > D000697 - Central Nervous System Stimulants C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant

   

alpha-PHP

alpha-PHP

C16H23NO (245.178)


   

Pinacidil

Pinacidil

C13H19N5 (245.164)


C - Cardiovascular system > C02 - Antihypertensives > C02D - Arteriolar smooth muscle, agents acting on > C02DG - Guanidine derivatives C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D049990 - Membrane Transport Modulators

   

(2E,4E,10E)-N-isobutyldodeca-2,4,10-trien-8-ynamide|2-Methylpropylamide 鈥樎?2E,4E,10E)-2,4,10-Dodecatrien-8-ynoic acid|dodeca-2E,4E,10E-trien-8-ynoic acid isobutylamide|N-isobutyldodeca-2E,4E,10E-triene-8-ynamide

(2E,4E,10E)-N-isobutyldodeca-2,4,10-trien-8-ynamide|2-Methylpropylamide 鈥樎?2E,4E,10E)-2,4,10-Dodecatrien-8-ynoic acid|dodeca-2E,4E,10E-trien-8-ynoic acid isobutylamide|N-isobutyldodeca-2E,4E,10E-triene-8-ynamide

C16H23NO (245.178)


   

2-Methylbutylamide-(Z)-2-Undecene-8,10-diynoic acid

2-Methylbutylamide-(Z)-2-Undecene-8,10-diynoic acid

C16H23NO (245.178)


   

1-Benzyl-2,2,6,6-tetramethylpiperidin-4-one

1-Benzyl-2,2,6,6-tetramethylpiperidin-4-one

C16H23NO (245.178)


   

Sophocarpine

Sophocarpine

C16H23NO (245.178)


   

(2E)-N-isobutyldodeca-2-ene-8,10-diynamide|(E)-N-isobutyl dodeca-2-ene-8,10-diynamide|(E)-N-isobutyldodeca-2-en-8,10-diynamide|(E)-N-isobutyldodeca-2-ene-8,10-diynamide|2-Methylpropylamide 鈥樎?E)-2-Dodecene-8,10-diynoic acid|Alk5|dodeca-2E-en-8,10-diynoic acid isobutylamide|dodeca-2E-ene-8,10-diynoic acid isobutylamide

(2E)-N-isobutyldodeca-2-ene-8,10-diynamide|(E)-N-isobutyl dodeca-2-ene-8,10-diynamide|(E)-N-isobutyldodeca-2-en-8,10-diynamide|(E)-N-isobutyldodeca-2-ene-8,10-diynamide|2-Methylpropylamide 鈥樎?E)-2-Dodecene-8,10-diynoic acid|Alk5|dodeca-2E-en-8,10-diynoic acid isobutylamide|dodeca-2E-ene-8,10-diynoic acid isobutylamide

C16H23NO (245.178)


   
   
   

(10S)-3,7,10-trimethyl-1,3a,4,8,9,9a,10,10a-octahydrocyclopenta[b]quinolizine-2-carbaldehyde

(10S)-3,7,10-trimethyl-1,3a,4,8,9,9a,10,10a-octahydrocyclopenta[b]quinolizine-2-carbaldehyde

C16H23NO (245.178)


   

DODEC-2-ENE-8,10-DIYNOIC ACID ISOBUTYLAMIDE

DODEC-2-ENE-8,10-DIYNOIC ACID ISOBUTYLAMIDE

C16H23NO (245.178)


   

Lys-val

6-amino-2-(2-amino-3-methylbutanamido)hexanoic acid

C11H23N3O3 (245.1739)


A dipeptide formed from L-lysine and L-valine residues.

   

Val-lys

2-(2,6-diaminohexanamido)-3-methylbutanoic acid

C11H23N3O3 (245.1739)


A dipeptide formed from L-valine and L-lysine residues.

   

NA 16:5

N-(2-Methylbutyl)-2E-undecene-8,10-diynamide

C16H23NO (245.178)


   

Inaperisone

1-(4-ethylphenyl)-2-methyl-3-pyrrolidin-1-ylpropan-1-one

C16H23NO (245.178)


C78281 - Agent Affecting Musculoskeletal System > C29696 - Muscle Relaxant Inaperisone is a centrally acting muscle relaxant. Inaperisone can inhibit the micturition reflex by acting indirectly on GABAB receptors in the brainstem[1].

   

N-(5,5,8,8-Tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)acetamide

N-(5,5,8,8-Tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)acetamide

C16H23NO (245.178)


   

3-(N-CYCLOHEXYLAMINO)PROPYLMETHYLDIMETHOXYSILANE

3-(N-CYCLOHEXYLAMINO)PROPYLMETHYLDIMETHOXYSILANE

C12H27NO2Si (245.1811)


   

1-(5,5,8,8-TETRAMETHYL-5,6,7,8-TETRAHYDRONAPHTHALEN-2-YL)ETHAN-1-ONE OXIME

1-(5,5,8,8-TETRAMETHYL-5,6,7,8-TETRAHYDRONAPHTHALEN-2-YL)ETHAN-1-ONE OXIME

C16H23NO (245.178)


   

(3,5-Ditert-butyl-4-hydroxyphenyl)acetonitrile

(3,5-Ditert-butyl-4-hydroxyphenyl)acetonitrile

C16H23NO (245.178)


   

(R)-3-METHYL-PYRROLIDINEHYDROCHLORIDE

(R)-3-METHYL-PYRROLIDINEHYDROCHLORIDE

C16H23NO (245.178)


   

1-Oxa-9-azaspiro[5.5]undecane, 9-(phenylmethyl)-

1-Oxa-9-azaspiro[5.5]undecane, 9-(phenylmethyl)-

C16H23NO (245.178)


   

(n-(3-trifluoromethyl)benzenesulfonyl)alanine

(n-(3-trifluoromethyl)benzenesulfonyl)alanine

C12H27NO2Si (245.1811)


   

Tetramethyljulolidine

Tetramethyljulolidine

C16H23NO (245.178)


   

9-methoxy-3-methyl-9-phenyl-3-azabicyclo[3.3.1]nonane

9-methoxy-3-methyl-9-phenyl-3-azabicyclo[3.3.1]nonane

C16H23NO (245.178)


   

N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine

N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine

C13H19N5 (245.164)


   

2-(2,6-Diaminohexanoylamino)-3-methylbutanoic acid

2-(2,6-Diaminohexanoylamino)-3-methylbutanoic acid

C11H23N3O3 (245.1739)


   

2-Heptyl-4-quinolinol

2-Heptyl-4-quinolinol

C16H23NO (245.178)


   

4-[3-(4-Aminobutylamino)propylamino]-4-oxobutanoic acid

4-[3-(4-Aminobutylamino)propylamino]-4-oxobutanoic acid

C11H23N3O3 (245.1739)


   

4-[4-(3-Aminopropylamino)butylamino]-4-oxobutanoic acid

4-[4-(3-Aminopropylamino)butylamino]-4-oxobutanoic acid

C11H23N3O3 (245.1739)


   

N-(2-Butenyl)-N-(1-phenylpropyl)propanamide

N-(2-Butenyl)-N-(1-phenylpropyl)propanamide

C16H23NO (245.178)


   

15-Methylaminobicyclo(8.3.2)pentadeca-1(13),10(15),11-trien-14-one

15-Methylaminobicyclo(8.3.2)pentadeca-1(13),10(15),11-trien-14-one

C16H23NO (245.178)


   

dezocine

dezocine

C16H23NO (245.178)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002491 - Central Nervous System Agents > D000700 - Analgesics N - Nervous system > N02 - Analgesics > N02A - Opioids

   
   

alpha-Pyrrolidinohexiophenone

alpha-Pyrrolidinohexiophenone

C16H23NO (245.178)


   

alpha-Pyrrolidinoisohexaphenone

alpha-Pyrrolidinoisohexaphenone

C16H23NO (245.178)


   

n-(2-methylbutyl)undec-2-en-8,10-diynimidic acid

n-(2-methylbutyl)undec-2-en-8,10-diynimidic acid

C16H23NO (245.178)


   

(2e,4z,10z)-n-(2-methylpropyl)dodeca-2,4,10-trien-8-ynimidic acid

(2e,4z,10z)-n-(2-methylpropyl)dodeca-2,4,10-trien-8-ynimidic acid

C16H23NO (245.178)


   

n-(2-methylpropyl)dodeca-2,4,10-trien-8-ynimidic acid

n-(2-methylpropyl)dodeca-2,4,10-trien-8-ynimidic acid

C16H23NO (245.178)


   

anhydrolycodoline

NA

C16H23NO (245.178)


{"Ingredient_id": "HBIN016168","Ingredient_name": "anhydrolycodoline","Alias": "NA","Ingredient_formula": "C16H23NO","Ingredient_Smile": "CC1CC2CC(=O)C3CCCN4C3(C1)C2=CCC4","Ingredient_weight": "245.36 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "38584","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "102442792","DrugBank_id": "NA"}

   

(2e)-n-(2-methylbutyl)undec-2-en-8,10-diynimidic acid

(2e)-n-(2-methylbutyl)undec-2-en-8,10-diynimidic acid

C16H23NO (245.178)


   

4-methyl-13-azatetracyclo[7.7.0.0¹,⁶.0²,¹³]hexadec-2-en-8-one

4-methyl-13-azatetracyclo[7.7.0.0¹,⁶.0²,¹³]hexadec-2-en-8-one

C16H23NO (245.178)


   

15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadec-2-en-11-one

15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadec-2-en-11-one

C16H23NO (245.178)


   

(2e)-n-[(2s)-2-methylbutyl]undec-2-en-8,10-diynimidic acid

(2e)-n-[(2s)-2-methylbutyl]undec-2-en-8,10-diynimidic acid

C16H23NO (245.178)


   

(2e,4e,10z)-n-(2-methylpropyl)dodeca-2,4,10-trien-8-ynimidic acid

(2e,4e,10z)-n-(2-methylpropyl)dodeca-2,4,10-trien-8-ynimidic acid

C16H23NO (245.178)


   

(1s,10r,13s,15r)-15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadec-2-en-11-one

(1s,10r,13s,15r)-15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadec-2-en-11-one

C16H23NO (245.178)


   

n-(2-methylpropyl)dodec-2-en-8,10-diynimidic acid

n-(2-methylpropyl)dodec-2-en-8,10-diynimidic acid

C16H23NO (245.178)


   

(2e,4z,10e)-n-(2-methylpropyl)dodeca-2,4,10-trien-8-ynimidic acid

(2e,4z,10e)-n-(2-methylpropyl)dodeca-2,4,10-trien-8-ynimidic acid

C16H23NO (245.178)


   

(2s)-2-{[(2s)-2,6-diamino-1-hydroxyhexylidene]amino}-3-methylbutanoic acid

(2s)-2-{[(2s)-2,6-diamino-1-hydroxyhexylidene]amino}-3-methylbutanoic acid

C11H23N3O3 (245.1739)


   

(1r,2r,4s,10r,13s,15s)-15-methyl-6-azapentacyclo[8.6.0.0¹,⁶.0²,¹³.0⁴,¹⁰]hexadecan-11-one

(1r,2r,4s,10r,13s,15s)-15-methyl-6-azapentacyclo[8.6.0.0¹,⁶.0²,¹³.0⁴,¹⁰]hexadecan-11-one

C16H23NO (245.178)


   

(2e)-n-(2-methylpropyl)dodec-2-en-8,10-diynimidic acid

(2e)-n-(2-methylpropyl)dodec-2-en-8,10-diynimidic acid

C16H23NO (245.178)


   

(2z)-n-(2-methylbutyl)undec-2-en-8,10-diynimidic acid

(2z)-n-(2-methylbutyl)undec-2-en-8,10-diynimidic acid

C16H23NO (245.178)


   

(2z,4e,10z)-n-(2-methylpropyl)dodeca-2,4,10-trien-8-ynimidic acid

(2z,4e,10z)-n-(2-methylpropyl)dodeca-2,4,10-trien-8-ynimidic acid

C16H23NO (245.178)


   

(1s,10s,13s,15r)-15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadec-2-en-11-one

(1s,10s,13s,15r)-15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadec-2-en-11-one

C16H23NO (245.178)


   

(2e,4e,10e)-n-(2-methylpropyl)dodeca-2,4,10-trien-8-ynimidic acid

(2e,4e,10e)-n-(2-methylpropyl)dodeca-2,4,10-trien-8-ynimidic acid

C16H23NO (245.178)


   

(2e)-n-(2-methylpropyl)dodeca-2,4,10-trien-8-ynimidic acid

(2e)-n-(2-methylpropyl)dodeca-2,4,10-trien-8-ynimidic acid

C16H23NO (245.178)